Anne White (she/her) is an executive vice president of Eli Lilly and Company and president of Lilly Neuroscience. She leads the late phase R&D and commercialization organizations for neuroscience for Eli Lilly and Company.

Anne has held a range of leadership roles across multiple areas of scientific research and development, including oncology, neuroscience and infectious disease. She has led the development of multiple late-phase opportunities and has led teams in the submission, approval and launch of several new medicines. She also led Lilly’s successful effort to significantly speed drug development from target identification through product launch.

Anne most recently served as senior vice president of Eli Lilly and Company and president of Lilly Oncology, with prior roles in R&D Leadership. She has over 25 years of experience in the pharmaceutical industry. Anne also has experience in small-company pharma, having founded and led a startup company in oncology drug development.

Anne was recently named to the Indiana 250 for 2022, a list of Indiana’s most influential and impactful business and community leaders. She was awarded the Lilly Women’s Network Award for her efforts in mentoring and supporting women in science and serves as the executive sponsor for Lilly’s LGBTQ employee resource group. Anne earned a bachelor’s degree in engineering from the University of Michigan.